Literature DB >> 28303850

Incidence and Risk Factors of De novo Stress Urinary Incontinence after Pelvic Floor Reconstruction: A Nested Case-control Study.

Shi-Yan Wang1, Ting-Ting Cao1, Run-Zhi Wang1, Xin Yang1, Xiu-Li Sun1, Jian-Liu Wang1.   

Abstract

BACKGROUND: Some patients with pelvic organ prolapse may suffer from lower urinary tract symptoms (LUTS), especially stress urinary incontinence (SUI) named de novo SUI after pelvic floor reconstruction. This study aimed to investigate the incidence and risk factors of de novo SUI.
METHODS: This is a nested case-control study of 533 patients who underwent pelvic floor reconstruction due to pelvic organ prolapse (POP) at the Department of Gynecology in Peking University People's Hospital from January 2011 to March 2013. According to the inclusion and exclusion criteria, 401 patients were enrolled in the study with the follow-up rate of 74.8% (101 patients lost to follow-up). There were 75 patients with de novo SUI postoperatively. According to the ratio of 1:3, we ensured the number of control group (n = 225). The preoperative urinary dynamics, POP-quantification scores, and LUTS were compared between the two groups by univariate and multivariate logistic regression analyses to investigate the risk factors of de novo SUI.
RESULTS: The incidence of de novo SUI was 25% (75/300). Univariate analysis showed that the ratio of lower urinary tract obstruction (LUTO) before surgery in de novo SUI group was significantly higher than the control group (odds ratio [OR] = 2.1, 95% confidence interval [CI] [1.1-4.0], P = 0.022). The interaction test of LUTO and other factors displayed that Aa value was an interaction factor. With the increasing score of Aa, the incidence of de novo SUI become higher (OR = 2.1, 95% CI [1.0-3.7], P = 0.045). After multivariable adjustment, multiple regression analysis showed that LUTO was independently associated with a greater risk of de novo SUI after pelvic floor surgery (OR = 2.3, 95% CI [1.2-4.6], P = 0.013).
CONCLUSIONS: Preoperative LUTO in patients with POP is a high-risk factor of de novo SUI, and high score of Aa-point is related to the occurrence of de novo SUI, which might be due to the outlet obstruction caused by bladder prolapse.

Entities:  

Mesh:

Year:  2017        PMID: 28303850      PMCID: PMC5358417          DOI: 10.4103/0366-6999.201592

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


Introduction

Pelvic organ prolapse (POP) is common in elderly women, with an incidence rate of about 50%.[1] The complex relationship between POP and urinary incontinence (UI) is likely attributed to their pathophysiology. POP, especially the prolapse of anterior vaginal wall, is often accompanied by lower urinary tract symptoms, such as stress urinary incontinence (SUI) and dysuria. In some patients, UI can be reduced due to obstruction of the urethra; however, leakage symptom may reappear or even be more severe than preoperative after prolapse correction. Indeed, some patients without complaint of SUI before surgery develop SUI after POP surgery which is called postoperative stress urinary incontinence (POSUI) or de novo stress urinary incontinence (de novo SUI).[2] Anterior vaginal prolapse may actually function to kink the urethra, maintaining stress continence by causing urethral obstruction. As a consequence, it is common for continent women who have undergone a successful POP surgery to develop SUI postoperatively. This might result from relieving the urethral obstruction caused by prolapse, thereby unmasking a preexisting compromised urethral function. SUI may be revealed only after prolapse reduction and is defined as occult stress urinary incontinence (OSUI).[2] OSUI is generally diagnosed before operation, by urodynamic study (UDS) or pressure-induced experiment after bladder prolapse restore. However, OSUI and POSUI cannot be exactly considered the same definition. Some patients reported that OSUI is the high-risk factor of de novo SUI, and some patients have no OSUI preoperative but develop POSUI, so OSUI and POSUI cannot be equated. In women without SUI, POP surgery may cause postoperative de novo SUI in 16–51%.[3456] Therefore, some surgeons prefer to perform anti-SUI surgery in patients undergoing pelvic floor reconstruction surgery. Some surgeons recommend a two-step procedure to avoid unnecessary operation and reduce the medical burden. There is no uniform standard to gauge the possibility of de novo SUI or SUI aggravation and predict the risk factors. Hence, we performed a nested case-control study of patients with severe POP who underwent pelvic reconstructive surgery to identify the high-risk factors of de novo SUI and try to provide a reference for clinicians while performing pelvic reconstructive surgery for POP patients.

Methods

Data resource

Data were collected from patients who underwent pelvic floor reconstructive surgery between January 2011 and March 2013 at the Department of Gynecology of Peking University People's Hospital. All patients were present of stage ≥3 POP confirmed by pelvic organ prolapse quantification (POP-Q). The total number was 533 cases. Patients who had no leakage but developed postoperative SUI were allocated into de novo SUI group, and in the control group, patients had no SUI before and after surgery. Data collected preoperatively and postoperatively included POP-Q staging, preoperative urodynamic parameters and 1-h pad test, and postoperative 1-h pad test in patients who developed SUI. Postoperative urodynamic test was conducted if necessary. Ethical approval for this study was granted by the Ethics Committee of Peking University People's Hospital (No. 2013-ethic-03). Written informed consent was obtained before sample collection.

Inclusion and exclusion criteria

Inclusion criteria: (1) patients with POP-Q staging ≥III; (2) patients who underwent pelvic reconstructive surgery; (3) preoperative pressure-induced test was negative; (4) preoperative urodynamic and 1-h pad test confirmed no objective SUI. Exclusion criteria: (1) patients had SUI before operation; (2) patients who underwent anti-SUI surgery preoperatively or simultaneously; (3) patients who took drug treatment for UI.

Data collection and follow-up

The pelvic floor follow-up database in our hospital was used; statistical data and general information of the patients were collected. Among the 533 patients, 401 patients met the inclusion criteria, after excluding 101 cases who lost to follow-up, totally 300 patients recruited in this study with the follow-up time of 3–24 months. Among the 300 patients, 75 underwent postoperative de novo SUI. According to the date of hospitalization of ±7 days and age of ±5 years, we set up the control group using the ratio of 1:3 to match the de novo SUI group and the number of control group was 225 cases [Figure 1]. All patients were asked to visit the gynecological clinic at 3, 12, and 24 months postoperatively. All these 300 patients completed OABSS and ICIQ questionnaires. For those who complained of leakage postoperatively, 1-h pad test and/or urodynamic examination (for serious cases) was conducted during outpatient review.
Figure 1

Flowchart of this study. anti-UI: anti-urinary incontinence; SUI: Stress urinary incontinence; POP: Pelvic organ prolapse.

Flowchart of this study. anti-UI: anti-urinary incontinence; SUI: Stress urinary incontinence; POP: Pelvic organ prolapse.

Outcome measures

Main measures: Risk factors of de novo SUI after pelvic floor surgery. Secondary measures: Ratio of de novo SUI after pelvic floor surgery.

Diagnostic criteria

Diagnosis was in accordance with the international standards for urinary control (International Continence Society).[2] SUI diagnostic methods included abdominal pressure at leakage of urine and 1-h pad test and pressure-induced test. Subjective SUI indicated that patients had chief complaint of SUI, with no objective evidence by the detective methods. Postoperative de novo SUI: Patients who had no objective SUI preoperative complained cough leakage postoperatively and had positive 1-h pad test or urodynamics SUI or positive pressure-induced test. Lower urinary tract obstruction (LUTO) was detected by UDS (Qmax ≤12 ml/s and PdetQmax ≥25 cmH2O[7] or residual urine ≥100 ml).

Statistical analysis

Statistical analysis was performed using SPSS version 16.0 software (SPSS Inc., Chicago, USA). The continuous data were described as mean ± standard deviation (SD) or median (quartile) and categorical variables as percentages of number. After testing the normality of the distributions of the variables, Student's t-test was used for the comparisons. Univariate and multivariate logistic regression models were used to examine factors associated with de novo SUI. In multivariate analysis, we included the variable frequency, C point, menopause, and hysterectomy. A value of P < 0.05 was considered statistically significant. This study is to analyze the relationship between risk factors and de novo SUI. We found that LUTO was the high-risk factor of postoperative de novo SUI. The incontinence rate of patients without LUTO was 22.4% in our preliminary study, to detect an odds ratio (OR) of 2.1 with two-sided 5% significance level and power of 80%, a sample size of 278 in total. In this observation cohort, de novo SUI occurred in 75 patients, so we conducted 1:3 matched nested case-control study; 300 patients in total achieved 83% power at 0.05 significance level to detect an OR of 2.1.

Results

Baseline characteristics of patients

Between January 2011 and March 2013, totally 533 patients underwent pelvic reconstructive surgery due to POP staging ≥III at Peking University People's Hospital, of which 401 cases met the inclusion standard, 300 cases were followed up on time with the follow-up rate of 74.8%. The median age of the patients was 66 years (39–90 years). The median delivery times were 2 (1–7 times). The surgery methods included 43 cases of native tissue repair, 170 of tension-free vaginal mesh (TVM) procedure, 63 of colpocleisis, 10 of sacrospinous ligament fixation, and 14 of sacral colpopexy. Baseline characteristics of the two groups were compared and there was no significant difference between the two groups [Table 1].
Table 1

Baseline characteristics of de novo SUI group and control group in which who had no SUI before and after surgery

CharacteristicsDe novo SUI group (n = 75)Control group (n = 225)StatisticsP
Age (years), mean ± SD64.3 ± 11.065.4 ± 10.00.774*0.439
Delivery times, mean ± SD2.4 ± 1.22.4 ± 1.30.079*0.937
Prolapse operation mode, n (%)6.6920.143
 Native tissue6 (8.0)37 (16.4)
 Colpocleisis13 (17.3)50 (22.2)
 TVM51 (68.0)119 (52.9)
 SSLF1 (1.3)9 (4.0)
 Sacral colpopexy4 (5.3)10 (4.4)
BMI (kg/m2), mean ± SD24.7 ± 3.624.3 ± 3.4−0.820*0.413
Hysterectomy, n (%)46 (61.3)165 (73.3)3.8820.058
COPD, n (%)5 (6.7)9 (4.0)0.8990.530
Menopause, n (%)59 (78.7)201 (85.5)2.1160.146
Hypertension, n (%)37 (49.3)110 (48.9)0.0041.000
Diabetes mellitus, n (%)17 (22.7)55 (24.4)0.3990.907
Heart disease, n (%)12 (16.0)32 (14.2)0.1420.851

*t values; †Chi-square values. SD: Standard deviation; SUI: Stress urinary incontinence; TVM: Tension-free vaginal mesh; SSLF: Sacrospinous ligament fixation; BMI: Body mass index; COPD: Chronic obstructive pulmonary disease.

Baseline characteristics of de novo SUI group and control group in which who had no SUI before and after surgery *t values; †Chi-square values. SD: Standard deviation; SUI: Stress urinary incontinence; TVM: Tension-free vaginal mesh; SSLF: Sacrospinous ligament fixation; BMI: Body mass index; COPD: Chronic obstructive pulmonary disease.

Grouping

Seventy-five patients among the 300 patients complained of different levels of SUI symptoms postoperatively and confirmed by pressure-induced test and 1-h pad test, those who had severe leakage or were suspected Mixture UI underwent UDS, the incidence rate of de novo SUI was 25%. According to the symptoms and the 1-h pad test, de novo SUI patients were divided into 3 degrees. Mild category only occurs in coughing and sneezing and 1-h pad test was ≥2 g and ≤10 g; moderate occurs in daily activities and 1-h pad was >10 g and ≤30 g; severe occurs in the change of posture and 1-h pad was >30 g. Conservative treatment such as pelvic floor muscle exercise (improved levator ani movement) was recommended for mild and moderate de novo SUI. A total of 46 patients were with mild de novo SUI and the rate was 61.3%, 20 moderate patients with the rate of 26.7%, and 9 severe patients with the rate of 12%. However, only 3 patients with severe de novo SUI underwent anti-incontinence surgery at 3, 6, and 8 months postoperatively. Four patients in de novo group who were repaired by TVM procedure recurred in these 75 cases. Control group Two hundred and twenty-five patients underwent POP repair at the same period with no complaint of SUI and were objectively confirmed with no SUI postoperatively, and the ratio was 75%. Ten of the 225 patients had been developed prolapse recurrent.

Analysis of high-risk factors of de novo stress urinary incontinence

There was no significant difference in body mass index (BMI), hysterectomy, history of chronic obstructive pulmonary disease (COPD), and menopause status of the two groups [Table 1]. Comparison of preoperative urine kinetic parameters and urination condition were performed between the two groups by univariate regression analysis. The results indicated that preoperative LUTO was the high-risk factor (P = 0.022) for de novo SUI after surgery [Table 2]. Furthermore, through the analysis of the interactions, Aa value was found to be the interaction factor for the occurrence of new SUI after preoperative urinary tract obstruction affecting POP operation (P < 0.05) [Table 3]. For covariate screening using the multiple regression equation adjusting for variable frequency, C point, menopause, and hysterectomy, P value of LUTO was <0.05, indicating that LUTO was the independent high-risk factor of de novo SUI after operation [Tables 2 and 4]. The results of single-factor analysis showed no significant difference among patients with different pelvic floor surgeries, indicating that the type of prolapse operation mode did not impact the incidence of de novo SUI [Table 1].
Table 2

Patients' urine, POP-Q staging, and logistic single factor regression analysis of urine kinetic parameters

ParametersDe novo SUI group (n=75)Control group (n=225)OR (95% CI)P
LUTO, n (%)19 (25.3)31 (13.8)2.1 (1.1–4.0)0.022
Preoperative detrusor instability, n (%)9 (12)23 (10.2)1.2 (0.5–2.7)0.666
Preoperative subjective SUI, n (%)17 (22.7)61 (27.1)0.8 (0.4–1.5)0.448
Preoperative UUI, n (%)4 (5.3)16 (7.1)0.7 (0.2–2.3)0.594
Aa-point, median (P25, P75)2.0 (0.0, 2.5)1.5 (0.0, 2.0)1.1 (0.9–1.2)0.468
Ba point, median (P25, P75)3.0 (2.0, 4.8)3.0 (2.0, 5.0)1.0 (0.9–1.1)0.880
C point, median (P25, P75)1.0 (0.3, 4.0)2.5 (0.0, 4.0)0.9 (0.9–1.0)0.087
Qmax (ml/s), median (P25, P75)17.0 (13.0, 22.6)17.6 (12.0, 23.2)1.0 (0.9–1.0)0.791
MUPP (cmH2O), median (P25, P75)59.5 (46.5, 82.5)60.0 (46.0, 83.5)1.0 (1.0–1.0)0.927

MUPP: Micturition urethral pressure measurement; UUI: Urgency urinary incontinence; SUI: Stress urinary incontinence; POP-Q: Pelvic organ prolapse quantification; OR: Odds ratio; CI: Confidence interval; LUTO: Lower urinary tract obstruction.

Table 3

Role of Aa in the development of urinary incontinence in patients with LUTO after pelvic floor surgery

LUTOAa-pointTotalOR (95% CI)PP value for interaction

Low (−3, −1)Middle (−1, 1)High (1, 3)
No30981222501.00.0450.044
Yes11732502.1 (1.0–3.7)

OR: Odds ratio; CI: Confidence interval; LUTO: Lower urinary tract obstruction.

Table 4

Multivariate regression analysis after LUTO, delivery times, C point, menopause, operation mode, and hysterectomy

Screening variablesOR (95% CI)P
LUTO2.3 (1.2–4.6)0.013
Delivery times1.1 (0.9–1.4)0.540
C point0.9 (0.9–1.0)0.192
Menopause0.7 (0.3–1.4)0.290
Operation mode1.3 (0.9–1.8)0.134
Hysterectomy0.6 (0.3–1.2)0.137

LUTO: Lower urinary tract obstruction; OR: Odds ratio; CI: Confidence interval.

Patients' urine, POP-Q staging, and logistic single factor regression analysis of urine kinetic parameters MUPP: Micturition urethral pressure measurement; UUI: Urgency urinary incontinence; SUI: Stress urinary incontinence; POP-Q: Pelvic organ prolapse quantification; OR: Odds ratio; CI: Confidence interval; LUTO: Lower urinary tract obstruction. Role of Aa in the development of urinary incontinence in patients with LUTO after pelvic floor surgery OR: Odds ratio; CI: Confidence interval; LUTO: Lower urinary tract obstruction. Multivariate regression analysis after LUTO, delivery times, C point, menopause, operation mode, and hysterectomy LUTO: Lower urinary tract obstruction; OR: Odds ratio; CI: Confidence interval.

Discussion

Symptoms of female pelvic floor dysfunction are diverse, including POP and UI. With the extensive development of pelvic floor surgery, postoperative stress urinary incontinence (POSUI) or de novo SUI is receiving greater attention. Full risk assessment of de novo SUI before operation helps make proper clinical decision. OSUI is closely related to the occurrence of de novo SUI. Anti-SUI surgery while performing pelvic floor reconstruction in the patients without preoperative SUI remains controversial. Some clinicians believe that all patients with no SUI should undergo middle segment suspension of urethra during vaginal repair.[8] Others believe that the high-risk factors for de novo SUI after surgery need to be identified before performing anti-UI surgery. Some studies have reported that the incidence of de novo SUI was 16–51%[3456] in women undergoing prolapse repair surgery without prophylactic anti-UI surgery. In a relatively new review, Al-Mande et al.[9] reported that the incidence of POSUI was 42% (subjective symptoms); they further analyzed the incidence of de novo SUI for 1–3 years after pelvic floor surgery of 100 POP women without previous SUI. The follow-up results showed that 25% (75/300) patients developed postoperative SUI after pelvic floor repair surgery, which was similar to previous reports. Several attempts were made to find high-risk factors and preventive methods of de novo SUI before surgery. Forsgren et al.[10] analyzed 907 patients and reported that the high-risk factors included preoperative SUI, BMI, and COPD. The recurrence in anterior POP may mask the SUI. The incidence of de novo SUI was high in patients undergoing hysterectomy.[10111213] Sun et al. summarized 140 cases and found that the high-risk factors of de novo SUI were preoperative SUI, obvious urethral prolapse, severe bladder prolapse, and low micturition urethral pressure measurement.[14] Kuribayashi et al.[15] reported that the ratio of de novo SUI was 37% in 65 patients after TVM operation, and preoperative urinary tract was the high-risk factor for de novo SUI. Single-factor analysis in the present study showed that preoperative urinary tract obstruction in the de novo SUI group was significantly higher than that in the contrast group. This was further confirmed by multiple regression, which showed that preoperative urinary tract obstruction was an independent high-risk factor for de novo SUI after operation, except C point, menopause, operation method, and hysterectomy [Table 4]. The reason for LUTO in POP was the increase of urethral resistance. After the operation, the obstruction is relieved and the urethra distortion is corrected, reducing the urethral pressure, which could change the OSUI to dominant SUI. This study suggested that the interaction of Aa with LUTO had an effect on the occurrence of postoperative SUI [Table 3]. The high score of Aa suggested that the urethra moved down and was highly active. Therefore, these patients were prone to SUI. Bladder prolapse could increase urethral resistance, masking SUI. Hence, SUI could appear after bladder prolapsed corrected. The results of this study were slightly different from previous studies, which suggested that high BMI and COPD before surgery were high-risk factors for POSUI. In contrast, the results of this study showed that BMI and COPD were not associated with the occurrence of de novo SUI, which might be related to the inclusion criteria and the number of cases. Several studies suggested methods to prevent the occurrence of de novo SUI. Pelvic floor reconstruction surgery accompanied with anti-SUI surgery could reduce the occurrence of SUI by 10–15%.[16] For patients confirmed with objective SUI after prolapse repair before surgery, it was normal to conduct anti-UI surgery to prevent SUI after surgery.[1718] However, some doctors prefer to put middle urethral suspension simultaneously for patients without SUI who underwent vaginal repair.[8] After pelvic floor prolapse, SUI could be caused by urethral pressure or curvature change or changes in urinary dynamics. Therefore, POP patients with no SUI may have OSUI, which may appear after the prolapse repair.[1920] Due to the fact that not all prolapse repair would develop SUI, surgeons need to determine whether the patients have risk of SUI after POP repair and perform anti-UI surgery along with POP repair. The study shows that preoperative LUTO in POP patients is a risk factor for the development of de novo SUI postoperatively. In addition, a greater Aa-point is related to the occurrence of de novo SUI, which might be due to outlet obstruction caused by bladder prolapse. Except other influence factors, patients with urinary obstruction caused by prolapse of bladder, especially whom with greater Aa-point, can be considered for prophylactic anti-incontinence surgery during POP repair surgery. In this study, the high-risk factor for the occurrence of de novo SUI after surgery was preoperative LUTO which can be mainly identified by urodynamic examination. The urodynamic examination played an important role in identifying OSUI and LUTO, so it was recommended as a routine examination for pelvic floor patients before operation. This study demonstrated that preoperative urinary tract obstruction was an independent predictor and Aa value was an interaction factor of de novo SUI. Therefore, urodynamic examination was recommended for POP patients with high Aa value. If the UDS shows urinary tract obstruction, simultaneous anti-SUI surgery is recommended to avoid POSUI. As an important method to find the urinary tract obstruction, UDS may help predict de novo SUI before surgery.

Financial support and sponsorship

This work is supported by a grant from the Chinese Preventive Medicine Association (No. 2119000216).

Conflicts of interest

There are no conflicts of interest.
  19 in total

1.  Predicting postoperative urinary incontinence development in women undergoing operation for genitourinary prolapse.

Authors:  A Bergman; P P Koonings; C A Ballard
Journal:  Am J Obstet Gynecol       Date:  1988-05       Impact factor: 8.661

2.  Incidence of stress urinary incontinence following vaginal repair of pelvic organ prolapse in objectively continent women.

Authors:  Hazem Al-Mandeel; Sue Ross; Magali Robert; Jill Milne
Journal:  Neurourol Urodyn       Date:  2011-01-31       Impact factor: 2.696

3.  The relationship of vaginal prolapse severity to symptoms and quality of life.

Authors:  G Alessandro Digesu; Charlotte Chaliha; Stefano Salvatore; Anna Hutchings; Vik Khullar
Journal:  BJOG       Date:  2005-07       Impact factor: 6.531

4.  Prevalence of abnormal urodynamic test results in continent women with severe genitourinary prolapse.

Authors:  B A Rosenzweig; S Pushkin; D Blumenfeld; N N Bhatia
Journal:  Obstet Gynecol       Date:  1992-04       Impact factor: 7.661

5.  Hysterectomy and urinary incontinence: a systematic review.

Authors:  J S Brown; G Sawaya; D H Thom; D Grady
Journal:  Lancet       Date:  2000-08-12       Impact factor: 79.321

6.  Vaginal hysterectomy and risk of pelvic organ prolapse and stress urinary incontinence surgery.

Authors:  Catharina Forsgren; Cecilia Lundholm; Anna L V Johansson; Sven Cnattingius; Jan Zetterström; Daniel Altman
Journal:  Int Urogynecol J       Date:  2011-08-18       Impact factor: 2.894

7.  A midurethral sling to reduce incontinence after vaginal prolapse repair.

Authors:  John T Wei; Ingrid Nygaard; Holly E Richter; Charles W Nager; Matthew D Barber; Kim Kenton; Cindy L Amundsen; Joseph Schaffer; Susan F Meikle; Cathie Spino
Journal:  N Engl J Med       Date:  2012-06-21       Impact factor: 91.245

Review 8.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.

Authors:  Bernard T Haylen; Dirk de Ridder; Robert M Freeman; Steven E Swift; Bary Berghmans; Joseph Lee; Ash Monga; Eckhard Petri; Diaa E Rizk; Peter K Sand; Gabriel N Schaer
Journal:  Int Urogynecol J       Date:  2009-11-25       Impact factor: 2.894

9.  Hysterectomy and risk of stress-urinary-incontinence surgery: nationwide cohort study.

Authors:  Daniel Altman; Fredrik Granath; Sven Cnattingius; Christian Falconer
Journal:  Lancet       Date:  2007-10-27       Impact factor: 79.321

Review 10.  Is there any evidence to advocate SUI prevention in continent women undergoing prolapse repair? An overview.

Authors:  B Fatton
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-10-21
View more
  3 in total

1.  Prophylactic midurethral sling insertion during transvaginal pelvic reconstructive surgery for advanced prolapse patients with high-risk predictors of postoperative de novo stress urinary incontinence.

Authors:  Tsia-Shu Lo; Sandy Chua; Chuan Chi Kao; Wu-Chiao Hsieh; Ming-Ping Wu; Ling-Hong Tseng
Journal:  Int Urogynecol J       Date:  2018-10-18       Impact factor: 2.894

2.  Correlations between Mitofusin 2 Expression in Fibroblasts and Pelvic Organ Prolapse: An In vitro Study.

Authors:  Ye Lu; Hua-Yun Chen; Xiao-Qing Wang; Jing-Xue Wang
Journal:  Chin Med J (Engl)       Date:  2017-12-20       Impact factor: 2.628

3.  Surgical Treatment of Stress Urinary Incontinence in Women in the Mainland of China: Current Status and Outlook.

Authors:  Lan Zhu
Journal:  Chin Med J (Engl)       Date:  2017-06-20       Impact factor: 2.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.